|
|
||||||||
Departments of 1 Surgery and
2 Pathology, Weiser, Martin R., Taine T. V. Pechet, Julian P. Williams,
Minghe Ma, Paul S. Frenette, Francis D. Moore, Lester Kobzik, Richard
O. Hines, Denisa D. Wagner, Michael C. Carroll, and Herbert B. Hechtman. Experimental murine acid aspiration injury is mediated
by neutrophils and the alternative complement pathway. J. Appl. Physiol. 83(4):
1090-1095, 1997.
complement activation; transgenic mice; inflammation; pneumonia; selectins
ASPIRATION OF ACIDIC gastric contents into distal
airways and alveoli occurs in patients with altered mental status,
abnormal swallowing mechanisms, or abnormal bowel motility, settings
that accompany stroke, induction of anesthesia, and drug intoxication. After an aspiration event, patients develop dyspnea, hypoxemia, and
diffuse pulmonary infiltrates in the setting of low pulmonary capillary
wedge pressures. These are the hallmarks of the acute respiratory
distress syndrome. Mortality after major aspiration is significant,
ranging between 30 and 94% in published reports (1, 7, 17).
Early studies describing the pathophysiology of acid aspiration
involved instillation of 1-4 ml/kg of 0.1 N HCl into the canine trachea, producing transient apnea and copious, protein-rich bronchial secretions. The instilled acid was neutralized within 10 min. The
subsequent response of hypoxia, increased microvascular permeability, and intravascular volume depletion led to hemoconcentration,
hypotension, and uniform mortality by 5 h (1). The authors ascribed the injury to direct distal airway and alveolar damage by the instilled acid.
Later studies have described a biphasic response, composed of an early
direct pulmonary injury due to acid, followed by a delayed inflammatory
injury mediated by polymorphonuclear leukocytes (PMNs). The second
component was shown in experiments of PMN depletion before aspiration,
which reduced lung injury by 66% (14). Injury-derived, locally
produced chemoactivators such as eicosanoids (9-11) and interleukins (5) were thought to recruit and activate the PMNs, leading
to their transmigration to alveolar spaces and bronchial walls (4).
Experimental inhibition of the above-mentioned agents reduced
leukosequestration and injury. The mechanism by which PMNs caused
injury beyond that, because of the direct effects of acid, was thought
to be release of peroxides and proteases (14) that damaged pneumocytes,
endothelium, and basement membranes, accounting for the capillary leak
syndrome after aspiration.
Complement (C) is also suspected to play a role in amplifying lung
injury after acid aspiration because inhibition of C activation with
soluble C receptor type 1 (sCR1) reduced pulmonary injury (18) in a rat
model of aspiration. sCR1 is the genetically engineered molecule
composed of the extracellular portion of CR1, which promotes the
dissociation of the C3 and C5 convertases (25), as well as the binding
and degradation of C4b and C3b, thereby inhibiting both the alternative
and classic C pathways. The mechanism by which C is activated after
aspiration has not been defined, nor is the way in which C activation
aggravates the injury. In general, C promotes inflammation via soluble
and cell-bound activation fragments. The soluble fragments (C3a and
C5a) act as anaphylotoxins, causing PMN recruitment, adhesion, and
activation. Cell-bound fragments such as the membrane attack complex
(C5b-9) cause cell injury or osmotic lysis or may act as adhesion
molecule counterreceptors, as in the case iC3b.
This study examines the self-destructive actions of inflammatory
mediators in acid aspiration lungs, specifically the relative roles of
PMNs and C in mediating the injury. We show that PMN depletion reduces
the injury by 59%. On the other hand, animals deficient in either P-
or E-selectin were not protected. Animals in which C activation was
prevented with sCR1 had a 54% reduction in injury indexes, similar to
the level of protection achieved in animals genetically deficient in C3
(58%). Animals genetically deficient in C4, a classic pathway
complement protein component, were not protected. Finally, animals that
were neutrophil depleted and treated with sCR1 showed an additive, 85%
reduction in injury indexes.
Acid aspiration may result in the development of
the acute respiratory distress syndrome, an event associated with
significant morbidity and mortality. Although once attributed to direct
distal airway injury, the pulmonary failure after acid aspiration is
more complex and involves an inflammatory injury mediated by complement
(C) and polymorphonuclear leukocytes. This study examines the injurious
inflammatory cascades that are activated after acid aspiration. The
role of neutrophils was defined by immunodepletion before aspiration,
which reduced injury by 59%. The injury was not modified in either P-
or E-selectin-knockout mice, indicating that these adhesion molecules
were not operative. C activation after aspiration was documented with
immunochemistry by C3 deposition on injured alveolar pneumocytes.
Animals in which C activation was inhibited with soluble C receptor
type 1 (sCR1) had a 54% reduction in injury, similar to the level of
protection seen in C3-knockout mice (58%). However C4-knockout mice
were not protected from injury, indicating that C activation is
mediated by the alternative pathway. Finally, an additive effect of
neutrophils and C was demonstrated whereby neutropenic animals that
were treated with sCR1 showed an 85% reduction in injury. Thus acid
aspiration injury is mediated by neutrophils and the alternative C
pathway.
Mice.
Male C57BL/6 mice were used for PMN-depletion and C-inhibition
experiments. C3-, C4- (27), P-selectin- (15), and E-selectin-deficient mice (8) were generated by gene targeting via homologous recombination in embryonic stem cells. All knockout strains were shown not to express
any detectable level of the proteins encoded by the respective targeted
genes. Animals used in this study were maintained in accord with the
guidelines of the Committee on Animals of the Harvard Medical School
and those prepared by the Committee on the Care and Use of Laboratory
Animals of the Institute of Laboratory Animal Resources, National
Research Council [DHHS publication no. (NIH) 85-23, Revised
1985].
Fig. 1.
Acid aspiration-induced lung injury is related to volume of 0.1 N HCl instilled into trachea. n = 5 Animals/group. An injury plateau was reached with minimal variability
at 2 ml/kg. Bars, SD.
[View Larger Version of this Image (8K GIF file)]
P < 0.05 compared with
sCR1-treated animals).
|
|||||||||||||||||||||||||||||||||||||||||
Instillation of 0.1 N HCl into the trachea of mice resulted in a pulmonary injury described by the extravasation of 125I-albumin into the interstitial and alveolar spaces. Acid aspiration (n = 10) resulted in a lung PI of 3.24 ± 0.31, significantly elevated compared with the PI of saline-aspirated (sham) animals (1.55 ± 0.05; n = 13, P < 0.05) (Fig. 2). The circulating neutrophil count did not significantly change during the aspiration protocol, with a mean absolute neutrophil count of 995 ± 113 cells/µl before and 1,395 ± 102 cells/µl 4 h after aspiration.
PMN-depleted mice. After acid aspiration, neutropenic mice (n = 11) with a mean absolute PMN count of 141 ± 43 cells/µl had a reduced lung PI of 2.25 ± 0.15 compared with acid-aspirated, neutrophil-sufficient mice, with a PI of 3.24 ± 0.31 (n = 10, P < 0.05) (Fig. 2). Serum C3 levels in PMN-depleted mice were not different from control animals, indicating that immunoneutralization of neutrophils did not activate C (data not shown). P- or E-selectin-deficient mice. Acid aspiration in P-selectin-knockout mice (n = 14) led to a lung PI of 2.48 ± 0.10, which was not significantly lower than that in the wild-type acid-aspirated control mice with a lung PI of 2.35 ± 0.14 (n = 12). Similarly, E-selectin-knockout mice (n = 20) were not protected from acid injury with a PI of 2.61 ± 0.10 that was not reduced compared with wild-type acid-aspirated control mice with a lung PI of 2.64 ± 0.10 (n = 13). Littermates undergoing sham aspiration with instillation of 0.9% saline into the distal airways (n = 9) had a lung PI of 1.60 ± 0.02 (Table 1). The injury after acid aspiration in the P- and E-selectin wild-type groups was lower than that seen in the other control groups. This is presumably because of the different genetic backgrounds and is the reason for using specific wild-type controls for each experiment. C-deficient and sCR1-treated mice. Inhibition of both alternative and classic pathway C activation was accomplished in mice by intravenous sCR1 before the instillation of acid. sCR1-treated mice (n = 12) had a lung PI of 2.32 ± 0.09, which is significantly reduced compared with that of C-sufficient mice (n = 23) with a lung PI of 3.22 ± 0.27 (P < 0.05). Similarly, mice genetically deficient in C3 (n = 10) were protected from acid aspiration with a lung PI of 2.26 ± 0.12 (P < 0.05), whereas C4-deficient mice (n = 10) had a lung PI of 3.18 ± 0.17 (not significant) (Fig. 3). In this set of experiments, saline-aspirated sham animals (n = 13) had a lung PI of 1.55 ± 0.05. C inhibition in neutrophil-depleted mice. To test for additive effects of C and neutrophils, a group (n = 5) of neutropenic mice (mean absolute PMN count of 140 ± 72 cells/µl) was treated with sCR1 before aspiration (Fig. 3). This combined-treatment group had a reduced lung PI of 1.86 ± 0.029 (P = 0.008 compared with sCR1 alone-treated animals but only P = 0.100 compared with PMN-depleted animals). C3 immunostaining. Lungs snap-frozen in optimal cutting-temperature compound 4 h after acid aspiration were stained for C3. C3 was localized on injured alveoli in acid-aspirated lungs (Fig. 4A). C3 was restricted to intravascular spaces in sham, saline-aspirated lungs (Fig. 4B).
This study examines the role of inflammatory mediators in acid aspiration lung injury. Because aspirated acid is rapidly neutralized by pulmonary secretions, to account for the observations that the damage intensifies over the subsequent 4 h, additional injurious mediators are postulated to be operative. The initial, direct tissue injury is amplified by an inflammatory reaction. We studied two components of this reaction, neutrophils and C.
Neutropenic mice had a 59% reduction in lung injury after acid aspiration. This confirms similar results reported in other species (9-11). Previous studies in the rat have shown that locally produced leukotriene B4 and thromboxane A2 recruit and activate neutrophils. Inhibiting eicosanoid synthesis by lavage with antagonists inhibited the influx of neutrophils (9). Other reports indicate that interleukin-8 (IL-8) levels rise in rabbit lung lavage fluid after acid aspiration. Immunoneutralization of this chemokine attenuates PMN sequestration and lung injury (5). Thus acid injury appears to stimulate eicosanoid and IL-8 release, likely from airway epithelial cells, alveolar epithelial cells, and/or alveolar macrophages. Recruited and activated PMNs release peroxides (26) and proteases (14), providing a mechanism by which to injure the endothelial and epithelial barrier, thereby allowing passage of protein-rich fluid into the interstitial and alveolar spaces.
PMNs interact with endothelial cells in an orderly and sequential
fashion via adhesion molecules (20). The selectin family of cell
surface proteins is thought to be responsible for the initial tethering
of neutrophils in the microvessels. P-selectin, contained in
Weibel-Palade bodies, is rapidly expressed on endothelial plasma
membranes after contact with chemoactivators (6, 13). E-selectin
requires gene expression and appears on endothelial cells several hours
after exposure to inflammatory cytokines such as IL-1 or tumor necrosis
factor-
(2). L-selectin is constitutively expressed on leukocytes
and is rapidly shed on their activation (23). Each selectin binds to a
glycoprotein counterreceptor expressing sialylated Lewis X-related
oligosaccharides, such as P-selectin glycoprotein ligand-1 (19). After
initial selectin interaction, it is generally accepted that rolling
PMNs become firmly attached to endothelium via the integrin family of
adhesion molecules (3), whereby the
2-integrins bind to endothelial intercellular adhesion molecule 1 and 2, part of the Ig
superfamily.
The operative adhesion molecule after acid aspiration was speculated to
be a selectin because studies have shown that
anti-
2-integrin therapy (immunoneutralization of CD18)
did not affect either neutrophil sequestration or lung injury (4, 5,
9-11). We used selectin-deficient mice to determine the role of
this adhesion molecule in acid aspiration injury. Surprisingly, neither
P- nor E-selectin alone played an indispensable role in our murine
aspiration model. To exclude an overlapping function of the selectin
adhesion molecules, double knockouts could be employed (21).
The mechanism by which neutrophils become sequestered in acid-aspirated
lungs is not clear. It does not appear to involve the selectin or
2-integrin (4, 5, 9-11)
family of adhesion molecules. Mechanical entrapment of circulating
platelet-neutrophil or neutrophil-neutrophil aggregates in lung
microvasculature is unlikely because aggregation requires selectin
and/or integrin adhesion molecules. Another possible mechanism
of entrapment involves elevated local concentrations of leukotriene
B4, thromboxane
A2, or IL-8 (5, 9-11), agents
that may change PMN deformability, leading to their entrapment and
activation in the pulmonary capillaries (16).
C activation, as well as PMN activation, can lead to self-destructive tissue injury. Previous reports have shown that the C inhibitor sCR1 reduced acid aspiration lung injury (18). In the present study, acid aspiration in C3 and C4 knockout mice was performed to determine the extent and pathway of C activation. C3-deficient animals, unable to activate C3 and subsequent C components via either pathway, were protected from injury (58%) to the same degree as animals treated with the C inhibitor sCR1 (54%). In contrast, C4-deficient animals, which are unable to activate C3 via the classic pathway but have an intact alternative activation pathway, were not protected from injury. These data lead us to conclude that the effect of sCR1 is due to inhibition of C3 activation and that C inhibition is as potent as PMN depletion in reducing lung injury. Also, C activation occurs via the alternative pathway. The interaction of C with lung tissue that produces C activation may be via an altered cell membrane or loss of membrane C regulatory proteins (22). With regard to the latter, acid exposure may cause loss of these normal protective mechanisms and thereby promote C activation. Indeed, we find C3 deposition on alveolae in mice aspirated with acid but not on those of mice aspirated with saline. These results are in contrast to other forms of inflammatory injury such as that after skeletal muscle ischemia. During reperfusion of hindlimb muscle, C is activated via the classic pathway (24). IgM is deposited on injured tissue, leading to the conclusion that ischemia results in altered cell immunogenicity, IgM binding, and subsequent C activation.
Local C activation may injure tissue by multiple independent mechanisms. First, the activation products C3a and C5a act as chemotaxins, stimulating the migration of leukocytes to the C-activation sites and upregulating cell adhesion molecules (2). Second, cell-bound C fragments such as iC3b act as adhesion counterreceptors and chemoactivators, signaling oxidative metabolism in neutrophils. Thus Rabinovici (18) found lung leukosequestration without injury in animals treated with C inhibitors, suggesting the importance of the second mechanism of action. Third, C activation can directly damage cells by formation of the membrane attack complex (C5b-9), which is a porelike structure that inserts itself into plasma membranes and allows indiscriminate movement of water and ions such as calcium. This results in a membrane perturbation, resulting in second messenger signaling, enzyme activation, and possible osmotic lysis (12). To study whether C acts through PMN recruitment/activation or independently by direct injury to cells, we inhibited C activation with sCR1 in neutropenic mice. These animals had an 85% reduction in lung permeability, significantly better than the 54% reduction seen by using single therapy with sCR1, indicating an effector role for neutrophils.
This study describes a novel mouse model of acid aspiration that uses extravasation of intravenous albumin as the primary marker of injury. This model is advantageous in its ability to utilize genetically altered animals to study inflammatory cascades. However, the model has obvious limitations because of animal size because it is not possible with present technology to draw serial blood samples for pulmonary physiological studies or to measure airway dynamics.
In conclusion, acid aspiration results in an inflammatory injury. Neutrophil depletion reduced the injury by 59%. Neither P- nor E-selectin-deficient animals were protected from injury. Inhibiting C activation with sCR1 reduced injury by 54%, similar to the protection seen in C3 knockout mice. C4 knockout mice, however, were not protected from injury, indicating that C activation occurs via the alternative pathway. Neutropenic animals treated with sCR1 had an 85% reduction in injury.
The authors thank D. Smith and R. A. Mercier for valuable help with the surgical preparations and A. C. Imrick for performing the immunohistochemistry.
Address for reprint requests: H. B. Hechtman, Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115.
Received 12 November 1996; accepted in final form 16 May 1997.
| 1. | Awe, W. C., W. S. Fletcher, and S. W. Jacob. The pathophysiology of aspiration pneumonitis. Surgery 60: 232-239, 1966. |
| 2. |
Bevilacqua, M. P.,
S. Stengelin,
M. A. Gimbrone, Jr.,
and
B. Seed.
Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.
Science
243:
1160-1165,
1989 |
| 3. |
Diamond, M. S.,
and
T. S. Springer.
A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM and fibrinogen.
J. Cell Biol.
120:
545-556,
1993 |
| 4. | Doerschuk, C. M., R. K. Winn, H. O. Coxsan, and J. M. Harlan. CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J. Immunol. 144: 2327-2333, 1990[Abstract]. |
| 5. | Folkesson, H. G., M. A. Matthay, C. A. Hebert, and V. C. Broaddus. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J. Clin. Invest. 96: 107-116, 1995. |
| 6. | Foreman, K. E., H. Vaporciyan, B. K. Bonish, M. L. Jones, K. J. Johnson, M. M. Glovsky, S. M. Eddy, and P. A. Ward. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94: 1147-1155, 1994. |
| 7. | Fowler, A. A., R. F. Hamman, J. T. Good, K. N. Benson, M. Vaird, D. J. Eberle, T. L. Petty, and T. M. Hyers. Adult respiratory distress syndrome: risk with common predispositions. Ann. Intern. Med. 98: 593-597, 1983. |
| 8. | Frenette, P. S., T. N. Mayadas, H. Rayburn, R. O. Hynes, and D. D. Wagner. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell 84: 563-574, 1996[Medline]. |
| 9. | Goldman, G., R. Welbourn, J. M. Klausner, L. Kobzik, C. R. Valeri, D. Shepro, and H. B. Hechtman. Leukocytes mediate acid aspiration-induced multiorgan edema. Surgery 114: 13-20, 1993[Medline]. |
| 10. | Goldman, G., R. Welbourn, L. Kobzik, C. R. Valeri, D. Shepro, and H. B. Hechtman. Synergism between leukotriene B4 and thromboxane A2 in mediating acid-aspiration injury. Surgery 111: 55-61, 1992[Medline]. |
| 11. |
Goldman, G.,
R. Welbourn,
L. Kobzik,
C. R. Valeri,
D. Shepro,
and
H. B. Hechtman.
Lavage with leukotriene B4 induces lung generation of tumor necrosis factor- that in turn mediates neutrophil diapedesis.
Surgery
113:
297-303,
1993[Medline].
|
| 12. |
Halperin, J. A.,
A. Taratuska,
M. Runkiewicz,
and
A. Nicholson-Weller.
Transient changes in erythrocyte membrane permeability are induced by sublytic amounts of the complement membrane attack complex (C5b-9).
Blood
81:
200-205,
1993 |
| 13. |
Hattori, R.,
K. K. Hamilton,
R. D. Fugate,
R. P. McEver,
and
P. J. Sims.
Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140.
J. Biol. Chem.
264:
7768-7771,
1989 |
| 14. | Knight, P. R., G. Druskovich, A. R. Tait, and K. J. Johnson. The role of neutrophils, oxidants, and proteases in the pathogenesis of acid pulmonary injury. Anesthesiology 77: 772-778, 1992[Medline]. |
| 15. | Mayadas, T. N., R. C. Johnson, H. Rayburn, R. O. Hynes, and D. D. Wagner. Leukocyte rolling and extravasation are severely compromised in P-selectin-deficient mice. Cell 74: 541-554, 1993[Medline]. |
| 16. | Motosugi, H., L. Graham, T. W. Noblitt, N. A. Doyle, W. M. Quinlan, Y. Li, and C. M. Doerschuk. Changes in neutrophil actin and shape during sequestration induced by complement fragments in rabbits. Am. J. Pathol. 149: 963-973. |
| 17. | Pepe, P. E., R. T. Potkin, D. H. Reus, L. D. Hudson, and C. J. Carrico. Clinical predictors of the adult respiratory distress syndrome. Am. J. Surg. 144: 124-130, 1982[Medline]. |
| 18. | Rabinovici, R., L. F. Neville, F. Abdullah, D. R. Phillip, J. Vernick, K. L. Fong, L. Hillegas, and G. Feuerstein. Aspiration-induced lung injury: role of complement. Crit. Care Med. 23: 1405-1411, 1995[Medline]. |
| 19. | Sako, D., X. J. Chang, K. M. Barone, G. Vachino, H. M. White, G. Shaw, G. M. Veldman, K. M. Bean, T. J. Ahern, B. Furie, D. A. Cumming, and G. R. Larsen. Expression cloning of a funtional glycoprotein ligand for P-selectin. Cell 75: 1179-1186, 1993[Medline]. |
| 20. | Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-304, 1994[Medline]. |
| 21. | Tang, T., P. S. Frenette, R. O. Hynes, D. D. Wagner, and T. N. Mayadas. Cytokine-induced meningitis is dramatically attenuated in mice deficient in endothelial selectin. J. Clin. Invest. 97: 2485-2490, 1996[Medline]. |
| 22. | Vakeva, A., B. P. Morgan, I. Tikkanen, K. Helin, P. Laurila, and S. Meri. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Am. J. Pathol. 144: 1357-1368, 1994[Abstract]. |
| 23. | Walcheck, B., J. Kahn, J. M. Fisher, B. B. Wang, R. S. Fisk, D. G. Payan, C. Feehan, R. Betageri, K. Darlak, A. F. Spatola, and T. K. Kishimoto. Neutrophil rolling altered by inhibition of L-selectin shedding in vitro. Nature 380: 720-723, 1996[Medline]. |
| 24. | Weiser, M. R., J. P. Williams, F. D. Moore, Jr., L. Kobzik, M. Ma, H. B. Hechtman, and M. C. Carroll. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183: 2342-2348, 1996. |
| 25. | Weisman, H. F., T. Barlow, M. K. Leppo, H. C. Marsh, Jr., G. R. Carson, M. F. Concino, M. P. Boyle, K. H. Roux, M. L. Weisfeldt, and D. T. Fearon. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249: 176-151, 1990. |
| 26. | Welbourn, C. R. B., G. Goldman, I. S. Paterson, C. R. Valeri, D. Shepro, and H. B. Hechtman. Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br. J. Surg. 78: 651-655, 1991. [Medline] |
| 27. |
Wessel, M. R.,
P. Butko,
M. Ma,
H. B. Warren,
A. L. Lage,
and
M. C. Carroll.
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.
Proc. Natl. Acad. Sci. USA
92:
11490-11494,
1995.
|
This article has been cited by other articles:
![]() |
S. Saglani, A. G. Nicholson, M. Scallan, I. Balfour-Lynn, M. Rosenthal, D. N. Payne, and A. Bush Investigation of young children with severe recurrent wheeze: any clinical benefit? Eur. Respir. J., January 1, 2006; 27(1): 29 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Matthay and G. A. Zimmerman Acute Lung Injury and the Acute Respiratory Distress Syndrome: Four Decades of Inquiry into Pathogenesis and Rational Management Am. J. Respir. Cell Mol. Biol., October 1, 2005; 33(4): 319 - 327. [Full Text] [PDF] |
||||
![]() |
K. Raghavendran, B. A. Davidson, B. A. Mullan, A. D. Hutson, T. A. Russo, P. A. Manderscheid, J. A. Woytash, B. A. Holm, R. H. Notter, and P. R Knight Acid and particulate-induced aspiration lung injury in mice: importance of MCP-1 Am J Physiol Lung Cell Mol Physiol, July 1, 2005; 289(1): L134 - L143. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ratajczak, R. Reca, M. Kucia, M. Majka, D. J. Allendorf, J. T. Baran, A. Janowska-Wieczorek, R. A. Wetsel, G. D. Ross, and M. Z. Ratajczak Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow Blood, March 15, 2004; 103(6): 2071 - 2078. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Parker and M. I. Townsley Evaluation of lung injury in rats and mice Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L231 - L246. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Marik Pharmacologic Strategies for the Treatment of Acute Respiratory Distress Syndrome: The Horizon is Getting Closer J Intensive Care Med, November 1, 2002; 17(6): 326 - 328. [PDF] |
||||
![]() |
K. Nakayama, Y. X. Jia, H. Hirai, M. Shinkawa, M. Yamaya, K. Sekizawa, and H. Sasaki Acid Stimulation Reduces Bactericidal Activity of Surface Liquid in Cultured Human Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., January 1, 2002; 26(1): 105 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kyriakides, Y. Wang, W. G. Austen Jr., J. Favuzza, L. Kobzik, F. D. Moore Jr., and H. B. Hechtman Sialyl Lewisx hybridized complement receptor type 1 moderates acid aspiration injury Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1494 - L1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.Y. Kazachkov, M.S. Muhlebach, C.A. Livasy, and T.L. Noah Lipid-laden macrophage index and inflammation in bronchoalveolar lavage fluids in children Eur. Respir. J., November 1, 2001; 18(5): 790 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mukundan, M. F. Gurish, K. F. Austen, H. B. Hechtman, and D. S. Friend The Presence of v-abl-transformed V3 Mast Cells in the Lungs Augments Pulmonary Vascular Permeability to Acid Aspiration J. Histochem. Cytochem., June 1, 2001; 49(6): 793 - 794. [Abstract] [Full Text] |
||||
![]() |
P. E. Marik Aspiration Pneumonitis and Aspiration Pneumonia N. Engl. J. Med., March 1, 2001; 344(9): 665 - 671. [Full Text] [PDF] |
||||
![]() |
Y. Song, N. Fukuda, C. Bai, T. Ma, M. A Matthay, and A S Verkman Role of aquaporins in alveolar fluid clearance in neonatal and adult lung, and in oedema formation following acute lung injury: studies in transgenic aquaporin null mice J. Physiol., June 15, 2000; 525(3): 771 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Nemzek, D. R. Call, S. J. Ebong, D. E. Newcomb, G. L. Bolgos, and D. G. Remick Immunopathology of a two-hit murine model of acid aspiration lung injury Am J Physiol Lung Cell Mol Physiol, March 1, 2000; 278(3): L512 - L520. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kyriakides, W. Austen Jr., Y. Wang, J. Favuzza, L. Kobzik, F. D. Moore Jr., and H. B. Hechtman Membrane attack complex of complement and neutrophils mediate the injury of acid aspiration J Appl Physiol, December 1, 1999; 87(6): 2357 - 2361. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |